{
    "root": "34297ff3-6fe5-d873-e063-6394a90a5f3e",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Doxepin",
    "value": "20250502",
    "ingredients": [
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "CROSPOVIDONE (120 .MU.M)",
            "code": "68401960MK"
        },
        {
            "name": "DOXEPIN HYDROCHLORIDE",
            "code": "3U9A0FE9N5",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_4711"
        }
    ],
    "indications": {
        "text": "doxepin tablets indicated treatment insomnia characterized difficulty sleep maintenance . trials performed support efficacy 3 months duration .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "dose doxepin tablets individualized .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "doxepin tablets 6 mg white white , round shaped biconvex tablets , `` p `` one side `` 013 `` side , supplied : ndc 72162-2475-3 : 30 tablets bottle store controlled room temperature 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . protect light . repackaged/relabeled : bryant ranch prepack , inc. burbank , ca 91504",
    "adverseReactions": "hypersensitivity doxepin hydrochloride , inactive ingredients , dibenzoxepines . ( 4.1 ) co-administration monoamine oxidase inhibitors ( maois ) : administer patient taking maois used maois within past two weeks . ( 4.2 ) untreated narrow angle glaucoma severe urinary retention . ( 4.3 )",
    "indications_original": "Doxepin Tablets are indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. The clinical trials performed in support of efficacy were up to 3 months in duration.",
    "contraindications_original": "The dose of Doxepin Tablets should be individualized.",
    "warningsAndPrecautions_original": "Doxepin Tablets 6 mg are white to off white, round shaped biconvex tablets, with \"P\" on one side and \"013\" on the other side, and are supplied as:\n                  \n                     NDC 72162-2475-3: 30 Tablets in a BOTTLE\n                  \n                  \n                  Store at controlled room temperature 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP Controlled Room Temperature]. Protect from light.\n                  \n                  Repackaged/Relabeled by:\n  \nBryant Ranch Prepack, Inc.\n  \nBurbank, CA 91504",
    "adverseReactions_original": "Hypersensitivity to doxepin hydrochloride, inactive ingredients, or other dibenzoxepines. (4.1) Co-administration with Monoamine Oxidase Inhibitors (MAOIs): Do not administer if patient is taking MAOIs or has used MAOIs within the past two weeks. (4.2) Untreated narrow angle glaucoma or severe urinary retention. (4.3)",
    "drug": [
        {
            "name": "Doxepin",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_4710"
        }
    ]
}